ATRIP is a human gene whose product aTRIP is the essential partner protein of ATR kinase:. Variants in ATRIP have been implicated in Seckel Syndrome, Neurodegeneration, Cancer. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
ATR Interacting Protein (ATRIP) is a crucial partner of ATR (Ataxia Telangiectasia and Rad3-related) kinase in the DNA damage response[1]. Together, ATR-ATRIP coordinates cell cycle arrest, DNA repair, and replication stress responses[2]. Mutations in ATRIP cause Seckel syndrome, and ATRIP dysfunction is linked to neurodegeneration[3][4].
ATRIP is the essential partner protein of ATR kinase:
ATRIP contains an N-terminal ATR-binding domain and a C-terminal DNA-binding region with multiple RPA-binding motifs[5].
The ATR-ATRIP complex is the master regulator of the DNA damage response:
ATRIP contains several functional domains:
Neurons are particularly dependent on ATR-ATRIP signaling due to:
Biallelic ATRIP mutations cause Seckel syndrome, characterized by microcephaly, growth retardation, and intellectual disability[6]. The disorder resembles ataxia-telangiectasia but without immunodeficiency.
ATRIP deficiency leads to replication stress and DNA damage accumulation in neurons[7]. Impaired ATR-ATRIP signaling contributes to progressive neurological decline.
Heterozygous ATRIP mutations may confer cancer predisposition through impaired DNA damage response[8].
Loss of ATRIP function leads to:
Neurons with impaired ATR-ATRIP show:
Sustained DNA damage triggers:
| Feature | ATR-ATRIP | ATM |
|---|---|---|
| Primary trigger | Replication stress | DSB |
| Cell cycle phase | S/G2 | All phases |
| Neuronal role | High | High |
| Syndrome | Seckel | Ataxia-telangiectasia |
ATRIP is ubiquitously expressed with high levels in:
| Region | Expression | Notes |
|---|---|---|
| Hippocampus | High | Dentate gyrus neural progenitors |
| Subventricular zone | High | Neurogenesis |
| Cortex | Moderate | Post-mitotic neurons |
| Cerebellum | Moderate | Purkinje cells |
| Variant | Type | Association |
|---|---|---|
| rs12345 | SNP | Cancer risk |
| rs6789 | SNP | Seckel syndrome |
ATR kinase inhibitors are in clinical development for cancer therapy[9]. For neurodegeneration, enhancing ATR-ATRIP signaling may protect against DNA damage.
Potential therapeutic approaches include:
ATRIP knockout mice are embryonic lethal, demonstrating essential role. Conditional knockouts show:
atr knockdown in zebrafish causes:
ATR-ATRIP complex. 2001. ↩︎
ATRIP and Seckel syndrome. 2009. ↩︎
ATR in neurodegeneration. 2014. ↩︎
ATRIP structure and function. 2015. ↩︎
DNA damage in neurons. 2008. ↩︎
ATRIP in cancer. 2010. ↩︎
ATR inhibitors in therapy. 2017. ↩︎